A Proof-of-Concept Study Investigating the Effects of Transcranial Plus Intranasal Photobiomodulation on Cognitive
Spencer W Liebel1, Paula K Johnson1,2, Hannah M Lindsey1
1George E. Wahlen VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.
Photobiomodulation, Photomedicine, and Laser Surgery
|July 25, 2025
Summary
Photobiomodulation (PBM) therapy shows promise for enhancing cognitive function in individuals with a history of repetitive head acceleration events (RHAEs). This treatment improved memory, attention, and executive functions in study participants.
Area of Science:
- Neuroscience
- Biomedical Engineering
Background:
- Repetitive head acceleration events (RHAEs) lack an effective rehabilitation standard.
- Cognitive impairments are a significant consequence of RHAEs.
Purpose of the Study:
- To investigate the efficacy of transcranial and intranasal photobiomodulation (PBM) for improving cognitive function.
- To assess PBM's impact on individuals with a history of RHAEs.
Main Methods:
- Forty-four participants with RHAE history received PBM treatment (810 nm LED headset and intranasal applicator) every other day for 8-10 weeks.
- Cognitive function was assessed using a comprehensive test battery before and after treatment.
- Data analyzed at group and individual levels using statistical tests and reliable change indices.
Main Results:
- Statistically significant group-level improvements were observed in fluid cognition, verbal learning/memory, attention, working memory, and executive functions.
- Individual-level analysis revealed reliable improvements in 0-36% of participants, particularly in attention and memory measures.
- Specific enhancements included improved verbal encoding, delayed recall, sustained attention, and cognitive switching.
Conclusions:
- Transcranial and intranasal PBM therapy appears to be a promising intervention for cognitive enhancement in individuals with RHAE history.
- PBM treatment may offer a novel approach for managing and preventing cognitive deficits associated with RHAEs.
- Further rigorous clinical trials are warranted to validate these findings and establish PBM as a standard treatment.


